Townsend & Associates, Inc Gilead Sciences, Inc. Transaction History

Townsend & Associates, Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 28, 2023	SELL	$76.01 - $86.7 $126,860 - $144,702	-1,669 Reduced 8.87%	17,152 $1.32 Million
Q1 2023 May 15, 2023	SELL	$77.31 - $88.08 $872,675 - $994,247	-11,288 Reduced 37.49%	18,821 $1.56 Million
Q4 2022 Feb 14, 2023	SELL	$62.32 - $89.47 $25,239 - $36,235	-405 Reduced 1.33%	30,109 $2.58 Million
Q3 2022 Nov 09, 2022	BUY	$59.54 - $68.01 $89,131 - $101,810	1,497 Added 5.16%	30,514 $2.51 Million
Q2 2022 Jul 18, 2022	BUY	$57.72 - $65.01 $129,870 - $146,272	2,250 Added 8.41%	29,017 $1.82 Million
Q1 2022 Apr 14, 2022	BUY	$57.92 - $72.58 $160,670 - $201,336	2,774 Added 11.56%	26,767 $1.67 Million
Q4 2021 Jan 18, 2022	BUY	$64.88 - $73.64 $1.56 Million - $1.77 Million	23,993 New	23,993 $1.72 Million

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Townsend & Associates, Inc, based on Form 13F filings with the SEC.

Stay updated on Townsend & Associates, Inc with notifications on news.